SCHEMBL25256944

SCHEMBL25256944

Nc1nc2ccc(Nc3ccnc(C(F)(F)F)c3)cc2s1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3CD O00329 3/20 0.53
PI4KA P42356 3/20 0.53
PIK3CG P48736 3/20 0.53
PI4KB Q9UBF8 3/20 0.53
PIK3CA P42336 2/20 0.53
PIK3CB P42338 2/20 0.53
EPHX2 P34913 3/20 0.52
SCN4A P35499 2/20 0.52
SYK P43405 1/20 0.52
RAB9A P51151 4/20 0.46
NPC1 O15118 3/20 0.46
LMNA P02545 3/20 0.46
HSD17B10 Q99714 3/20 0.46
USP2 O75604 2/20 0.46
SMN1; SMN2 Q16637 2/20 0.46
PKM P14618 2/20 0.46
GAA P10253 2/20 0.46
KCNH2 Q12809 1/20 0.46
GMNN O75496 1/20 0.46
TP53 P04637 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31114585 1.00 PIK3CD (0.53) PIK3CDPI4KAPIK3CGPI4KBPIK3CA
SCHEMBL30451155 0.83 SYK (0.55) PIK3CDPI4KAPIK3CGPI4KBPIK3CA
SCHEMBL25303974 0.83 SYK (0.55) PIK3CDPI4KAPIK3CGPI4KBPIK3CA
SCHEMBL30450911 0.83 LCK (0.46) PIK3CAEPHX2RAB9ANPC1CYP3A4
SCHEMBL31114573 0.79 KMT2A (0.68) PIK3CDPI4KAPIK3CGPI4KBPIK3CA
SCHEMBL25262011 0.79 KMT2A (0.68) PIK3CDPI4KAPIK3CGPI4KBPIK3CA
SCHEMBL25303609 0.79 EPHX2 (0.51) PIK3CDPI4KAPIK3CGPI4KBPIK3CA
SCHEMBL31114583 0.79 EPHX2 (0.51) PIK3CDPI4KAPIK3CGPI4KBPIK3CA
SCHEMBL21186294 0.77 RAB9A (0.59) PIK3CDPI4KAPIK3CGPI4KBPIK3CA
SCHEMBL25304126 0.77 SYK (0.55) PIK3CDPI4KAPIK3CGPI4KBPIK3CA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250382273-A1 BENZOTHIAZOLE ANAOLOGUES AND USE THEREOF AS BOOSTERS OF ANTI TUBERCULOSIS DRUGS INST NAT SANTE RECH MED (FR) 2025-12-18 US disclosed
EP-4460500-A1 BENZOTHIAZOLE ANAOLOGUES AND USE THEREOF AS BOOSTERS OF ANTI TUBERCULOSIS DRUGS INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE - INSERM (FR) 2024-11-13 EP disclosed
WO-2023131649-A1 BENZOTHIAZOLE ANAOLOGUES AND USE THEREOF AS BOOSTERS OF ANTI TUBERCULOSIS DRUGS INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) (FR) 2023-07-13 WO disclosed
WO-2023131649-A1 BENZOTHIAZOLE ANAOLOGUES AND USE THEREOF AS BOOSTERS OF ANTI TUBERCULOSIS DRUGS INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) (FR) 2023-07-13 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250382273-A1 BENZOTHIAZOLE ANAOLOGUES AND USE THEREOF AS BOOSTERS OF ANTI TUBERCULOSIS DRUGS BBOX1, NDUFB6, NDUFB5 PIK3CD 3384/4885PI4KA 4333/4885PIK3CG 3871/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.